Full Ratchet Anti-Dilution

A full ratchet anti-dilution provision is a shareholder protection that lowers the conversion price of preferred stock all the way down to the lowest price paid by any investor in any later financing round. If a company that issued Series A preferred at $10 per share later sells Series B at $5, a full ratchet automatically reprices the Series A shares to $5—guaranteeing them a share of the upside as if they had paid the lower price, but devastating the founders’ ownership.

The protection and the cost

A preferred stock investor buys shares with the hope that the company will raise future rounds at higher prices. If it does, the preferred investor’s conversion into common stock occurs at the original entry price, delivering strong returns. But if the company stumbles and a future round comes at a lower price—a down round—the preferred investor faces dilution: their $10 investment is now worth less on paper.

An anti-dilution provision compensates the investor by adjusting the conversion formula. A full ratchet is the most investor-friendly version: it reprices the preferred shares as if they were purchased at the lowest price paid by any investor in any subsequent round, regardless of the dollar volume or the number of shares issued at that price.

This creates brutal consequences for common shareholders, particularly founders. If the company holds up through a Series A ($10), Series B ($8), and Series C ($3), the Series A preferred holders get repriced all the way to $3—even though only a small fraction of Series C was issued at that price. The common shareholders (typically the founders) are diluted by the full magnitude of the repricing.

How the math works

Suppose a founder owns 1 million shares of common stock, and a Series A preferred investor buys 1 million Series A shares at a $10 per-share price. The company is valued at $20 million: 1 million common, 1 million preferred, at $10 per share.

In Series B, the company is struggling. New investors offer $8 per share, and the board accepts. No full ratchet clause exists; the Series B trades on different terms. But if a full ratchet were in place, the Series A preferred shares automatically reprice downward.

Now suppose Series C: a down round at $3 per share. The full ratchet triggers again. The Series A preferred shares—and any other preferred with a full ratchet—reprice to $3. What does this mean for the founder’s common stock?

The Series A investor now effectively has the same per-share value as if they had bought at $3. They originally bought 1 million shares at $10 (a $10 million investment). Repriced at $3, those shares now represent $3 million of invested capital. The investor is whole on the downside but has not gained the shares; instead, the conversion formula changes so that when they convert, they get more common shares per preferred share held.

The founder’s ownership percentage shrinks because the fully-repriced preferred now claims a larger share of the post-dilution equity base. If the company later recovers, the founder’s return is crippled by the repricing they endured while the preferred investor was protected.

Why investors demand full ratchets in early rounds

Full ratchet clauses are most common in seed and Series A rounds, especially in volatile sectors like biotech, where clinical trial failures or prototype setbacks are normal. An investor buying at a $10 valuation in a biotech company faces genuine downside risk; a full ratchet is seen as legitimate protection.

Founders in early-stage companies often have little negotiating power. They need capital urgently, and a sophisticated investor brings not just money but credibility and connections. The founder’s common stock is already heavily diluted by the investor’s preferred; accepting a full ratchet often feels like a cost of doing business.

Additionally, early-stage investors see themselves as betting on the team and the market, not the valuation itself. They expect multiple down rounds as the company iterates and de-risks. A full ratchet ensures they do not lose ground to common shareholders if the valuation stumbles.

The entrenchment problem: where full ratchets become dangerous

Full ratchet clauses are so harsh that they can create a perverse incentive: once triggered, they sometimes discourage future fundraising because the repricing is so damaging.

Consider a founder-friendly investor in Series A who accepted a broad-based weighted average anti-dilution clause instead of a full ratchet. If Series B comes at a lower price, the weighted average repricing is moderate, and the company can move forward. But with a full ratchet in place, the founders face existential dilution. They may resist new funding rather than accept it, even if the company needs capital to survive.

This is the entrenchment trap: the anti-dilution clause designed to protect investors can end up protecting founders’ control (by discouraging down rounds) at the expense of the company’s ability to raise capital. In the worst case, a company with aggressive full ratchet clauses cannot raise Series B at any price because the repricing would be so destructive.

Some later-round investors demand carve-outs: a full ratchet might not apply to equity issued to employees, granted as options, or raised in convertible debt. These carve-outs limit the damage but do not eliminate it.

When full ratchets make sense—and when they do not

A full ratchet is most defensible in a few contexts. First, a small “bridge” financing at a lower price—say, a one-month funding of $1 million at $8, supporting the company toward a larger Series B at $12—might justify full ratchet protection for the early investor. The bridge is temporary; the repricing is a momentary technical penalty.

Second, in industries with binary outcomes (biotech, deep tech), where companies face genuine clinical or technical milestones and large price swings are normal, investors are more justified in demanding full ratchet protection at the outset.

But in most venture and growth equity contexts—consumer software, services, late-stage venture—full ratchets are contractual overkill and are increasingly seen as a founder-unfriendly negotiating position. Mature investors recognize that full ratchets are often waived or renegotiated in later rounds anyway, because down rounds are so demoralizing that a new investor will insist on a clean re-capitalization to move forward.

The shift toward broad-based weighted average

The venture capital and growth equity markets have largely moved away from full ratchet clauses in favor of broad-based weighted average anti-dilution. A weighted average reprices preferred shares based on the weighted-average price of all equity issued in the down round, not just the single lowest price. If the company sells 100,000 shares at $3 in Series C but 1 million shares at $6, the weighted-average price is ~$5.70, and the repricing is moderate.

This shift reflects a mutual recognition: investors need protection from down rounds, but founders need to survive to achieve recovery. A full ratchet is a blunt instrument that can become counterproductive. A weighted average balances both interests.

Founders negotiating preferred stock terms today should understand that full ratchet clauses are negotiable. Accepting them in a seed round is common, but later-stage investors and later-round notes often include weighted average instead. The key is to surface anti-dilution language early and challenge overly harsh terms before they become buried in the term sheet.

See also